Evidence map›Paper›PMID 34446153›Full record

ArticleBiological psychiatry2021

mGlu

Mariacristina Mazzitelli, Volker Neugebauer

Abstract readComment
In one paragraph

Article in Biological psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Discovery of VU6052959/BI'7927: A Selective mGluACS medicinal chemistry letters · 2026
    Article
  2. Article
  3. Further Optimization of the mGluACS chemical neuroscience · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Mariacristina MazzitelliDepartment of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.
Volker NeugebauerDepartment of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas; Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, Texas; Garrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, Texas. Electronic address: volker.neugebauer@ttuhsc.edu.

Funding

PAIN, NOCICEPTION, AND THE AMYGDALAR01NS038261 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Volker Neugebauer, Igor Ponomarev · 1999 to 2026
$8.7M
Stress-induced descending facilitation from amygdala kappa opioid receptors in functional painR01NS106902 · NINDS · UNIVERSITY OF ARIZONA · PI NEUGEBAUER, VOLKER, PORRECA, FRANK · 2018 to 2022
$2.7M
Trans-synaptic signaling complex in amygdala pain mechanismsR01NS118731 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR, NEUGEBAUER, VOLKER · 2020 to 2024
$2.7M
Pronociceptive and antinociceptive opioid mechanisms in the central nucleus of the amygdalaR01NS109255 · NINDS · UNIVERSITY OF ARIZONA · PI JI, GUANGCHEN, NAVRATILOVA, EDITA · 2019 to 2023
$2.5M
NINDS NIH HHS R01 NS038261NINDS NIH HHS R01 NS106902NINDS NIH HHS R01 NS109255NINDS NIH HHS R01 NS118731
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Receptors, Metabotropic GlutamateSchizophreniaHumansReceptors, Metabotropic Glutamate

Identifiers

PMID34446153
PMCPMC9359128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.